2m 2m 2m 2m 2m 2m 2m
VOR BIOPHARMA (VOR)
NASDAQ
$18.82+$0.32 (+1.73%)
Price as of Jul 14, 2026 7:51 PM EDT- $977.0MMarket Cap
- -62.28%1-Year Change
- BiotechnologyIndustry
VOR BIOPHARMA (VOR)
$18.82+$0.32 (+1.73%)
VOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.50 | ||
Change | -$1.11 (-5.80%) | ||
Open | $18.13 | ||
High | $18.91 | ||
Low | $18.01 | ||
Previous Close | $18.03 | ||
Volume | 896,192 | ||
30-Day Average Volume | 1,998,424 | ||
1-Week Change | -10.30% | ||
1-Month Change | 25.56% | ||
1-Year Change | -62.28% | ||
3-Year Change | -69.65% | ||
5-Year Change | -94.65% | ||
Fundamentals | |||
Shares Outstanding | 54.2M | ||
Total Assets | $506.7M | ||
Market Cap | $977.0M | ||
Enterprise Value | $807.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$219.6M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$219.6M | ||
EBITDA | -$219.6M | ||
Net Working Capital | $484.7M | ||
EPS | -$5.11 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -6 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue